Year |
Citation |
Score |
2023 |
Guimarães DM, Valério-Gomes B, Vianna-Barbosa RJ, Oliveira W, Neves GÂ, Tovar-Moll F, Lent R. Social isolation leads to mild social recognition impairment and losses in brain cellularity. Brain Structure & Function. PMID 37690044 DOI: 10.1007/s00429-023-02705-z |
0.423 |
|
2023 |
Gonçalves PFR, Nunes LED, Andrade BDS, Silva MOLD, Souza INO, Assunção-Miranda I, Castro NG, Neves GA. Age-dependent memory impairment induced by co-exposure to nicotine and a synthetic cannabinoid in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 127: 110821. PMID 37442332 DOI: 10.1016/j.pnpbp.2023.110821 |
0.734 |
|
2020 |
Marques AM, Macena MV, Cardoso AR, Hammes CSO, Pinheiro FML, Castro NG, Neves GA. Effects of combined 5-HT and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice. Psychopharmacology. PMID 32095916 DOI: 10.1007/S00213-020-05485-0 |
0.733 |
|
2019 |
Monteiro J, Assis-de-Lemos G, de-Souza-Ferreira E, Marques AM, Neves GA, Silveira MS, Galina A. Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis. Journal of Bioenergetics and Biomembranes. PMID 31853754 DOI: 10.1007/S10863-019-09816-5 |
0.544 |
|
2019 |
Neves GA, Grace AA. α7 nicotinic receptor full agonist reverse basolateral amygdala hyperactivity and attenuation of dopaminergic neuron activity in rats exposed to chronic mild stress. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31615702 DOI: 10.1016/J.Euroneuro.2019.09.009 |
0.499 |
|
2019 |
Figueiredo CP, Barros-Aragão FGQ, Neris RLS, Frost PS, Soares C, Souza INO, Zeidler JD, Zamberlan DC, de Sousa VL, Souza AS, Guimarães ALA, Bellio M, Marcondes de Souza J, Alves-Leon SV, Neves GA, et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nature Communications. 10: 3890. PMID 31488835 DOI: 10.1038/S41467-019-11866-7 |
0.737 |
|
2019 |
Grace A, Neves G. 23.2 ALPHA 7 NICOTINIC MODULATORS REVERSE THE HYPERDOPAMINERGIC TONE IN THE MAM MODEL OF SCHIZOPHRENIA Schizophrenia Bulletin. 45: S126-S126. DOI: 10.1093/Schbul/Sbz022.092 |
0.463 |
|
2019 |
Nunes LE, Neves G, Castro N, Andrade B, Cunha G, Cunha N, Lione T, Nazareth N, Marques A, Ferreira B, Diniz F, Ferreira G. Blockade of cannabinoid type 2 receptor inhibits a working memory impairment relevant for schizophrenia Ibro Reports. 6: S447. DOI: 10.1016/J.Ibror.2019.07.1413 |
0.733 |
|
2018 |
Neves GA, Grace AA. α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29695783 DOI: 10.1038/S41386-018-0066-0 |
0.528 |
|
2018 |
Dias Viegas FP, de Freitas Silva M, Divino da Rocha M, Castelli MR, Riquiel MM, Machado RP, Vaz SM, Simões de Lima LM, Mancini KC, Marques de Oliveira PC, Morais ÉP, Gontijo VS, da Silva FMR, D'Alincourt da Fonseca Peçanha D, Castro NG, ... Neves GA, et al. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates. European Journal of Medicinal Chemistry. 147: 48-65. PMID 29421570 DOI: 10.1016/J.Ejmech.2018.01.066 |
0.764 |
|
2018 |
Neves G, Grace A. S232. ALPHA7 NICOTINIC RECEPTOR AGONISTS REVERSE THE HYPERDOPAMINERGIC STATE IN THE MAM MODEL OF SCHIZOPHRENIA Schizophrenia Bulletin. 44: S416-S417. DOI: 10.1093/Schbul/Sby018.1019 |
0.528 |
|
2017 |
Neves G, Borsoi M, Antonio CB, Pranke MA, Betti AH, Rates SMK. Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects. Anais Da Academia Brasileira De Ciencias. 0. PMID 28832723 DOI: 10.1590/0001-3765201720160844 |
0.372 |
|
2017 |
Matias I, Diniz LP, Buosi A, Neves G, Stipursky J, Gomes FCA. Flavonoid Hesperidin Induces Synapse Formation and Improves Memory Performance through the Astrocytic TGF-β1. Frontiers in Aging Neuroscience. 9: 184. PMID 28659786 DOI: 10.3389/Fnagi.2017.00184 |
0.329 |
|
2017 |
Dias KS, de Paula CT, Dos Santos T, Souza IN, Boni MS, Guimarães MJ, da Silva FM, Castro NG, Neves GA, Veloso CC, Coelho MM, de Melo IS, Giusti FC, Giusti-Paiva A, da Silva ML, et al. Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 130: 440-457. PMID 28282613 DOI: 10.1016/J.Ejmech.2017.02.043 |
0.686 |
|
2013 |
Neves G, Antonio CB, Betti AH, Pranke MA, Fraga CA, Barreiro EJ, Noël F, Rates SM. New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia. Behavioural Brain Research. 237: 86-95. PMID 23000351 DOI: 10.1016/J.Bbr.2012.09.016 |
0.707 |
|
2010 |
Pazini F, Menegatti R, Sabino JR, Andrade CH, Neves G, Rates SM, Noël F, Fraga CA, Barreiro EJ, de Oliveira V. Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581. Bioorganic & Medicinal Chemistry Letters. 20: 2888-91. PMID 20363131 DOI: 10.1016/J.Bmcl.2010.03.034 |
0.67 |
|
2010 |
Neves G, Menegatti R, Antonio CB, Grazziottin LR, Vieira RO, Rates SM, Noël F, Barreiro EJ, Fraga CA. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. Bioorganic & Medicinal Chemistry. 18: 1925-35. PMID 20153652 DOI: 10.1016/J.Bmc.2010.01.040 |
0.699 |
|
2008 |
Conrado DJ, Verli H, Neves G, Fraga CA, Barreiro EJ, Rates SM, Dalla Costa T. Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype. The Journal of Pharmacy and Pharmacology. 60: 699-707. PMID 18498705 DOI: 10.1211/Jpp.60.6.0004 |
0.667 |
|
2008 |
Neves G, Kliemann M, Betti AH, Conrado DJ, Tasso L, Fraga CA, Barreiro EJ, Teresa Dalla Costa, Rates SM. Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581. Pharmacology, Biochemistry, and Behavior. 89: 23-30. PMID 18082872 DOI: 10.1016/J.Pbb.2007.10.018 |
0.687 |
|
2005 |
Tasso L, Neves G, Menegatti R, Fraga CA, Barreiro E, Eifler-Lima V, Rates SM, Costa TD. Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 26: 194-202. PMID 16076552 DOI: 10.1016/J.Ejps.2005.06.002 |
0.676 |
|
2004 |
Neves G, Rates SMK, Fraga CAM, Barreiro EJ. Agentes dopaminérgicos e o tratamento da disfunção erétil QuíMica Nova. 27: 949-957. DOI: 10.1590/S0100-40422004000600020 |
0.308 |
|
2003 |
Tasso L, Neves G, Menegatti R, Fraga CA, Barreiro EJ, Eifler-Lima VL, Rates SM, Dalla Costa T. Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasma. Journal of Pharmaceutical and Biomedical Analysis. 33: 1127-33. PMID 14656603 DOI: 10.1016/S0731-7085(03)00407-2 |
0.623 |
|
2003 |
Menegatti R, Cunha AC, Ferreira VF, Perreira EF, El-Nabawi A, Eldefrawi AT, Albuquerque EX, Neves G, Rates SM, Fraga CA, Barreiro EJ. Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands. Bioorganic & Medicinal Chemistry. 11: 4807-13. PMID 14556797 DOI: 10.1016/S0968-0896(03)00487-5 |
0.673 |
|
2003 |
Neves G, Fenner R, Heckler AP, Viana AF, Tasso L, Menegatti R, Fraga CA, Barreiro EJ, Dalla-Costa T, Rates SM. Dopaminergic profile of new heterocyclic N-phenylpiperazine derivatives. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De BiofãSica ... [Et Al.]. 36: 625-9. PMID 12715082 DOI: 10.1590/S0100-879X2003000500010 |
0.706 |
|
2003 |
Amaral PdA, Neves G, Farias F, Eifler-Lima VL. Química combinatória: moderna ferramenta para a obtenção de candidatos a protótipos de novos fármacos Revista Brasileira De CiêNcias FarmacêUticas. 39: 351-363. DOI: 10.1590/S1516-93322003000400002 |
0.312 |
|
2000 |
Daudt R, von Poser GL, Neves G, Rates SM. R. Daudt, G. L. Von poser, G. Neves and S. M. K. Rates, 'Screening for the antidepressant activity of some species of hypericum from south Brazil'. Phytotherapy research14(5) 2000, 344-346 Phytotherapy Research : Ptr. 14: 661. PMID 11114012 DOI: 10.1002/1099-1573(200012)14:8<661::Aid-Ptr806>3.0.Co;2-V |
0.603 |
|
2000 |
de-Paris F, Neves G, Salgueiro JB, Quevedo J, Izquierdo I, Rates SM. Psychopharmacological screening of Pfaffia glomerata Spreng. (Amarathanceae) in rodents. Journal of Ethnopharmacology. 73: 261-9. PMID 11025164 DOI: 10.1016/S0378-8741(00)00329-9 |
0.658 |
|
2000 |
Daudt R, von Poser GL, Neves G, Rates SM. Screening for the antidepressant activity of some species of Hypericum from South Brazil. Phytotherapy Research : Ptr. 14: 344-6. PMID 10925399 DOI: 10.1002/1099-1573(200008)14:5<344::Aid-Ptr586>3.0.Co;2-3 |
0.657 |
|
Show low-probability matches. |